StockData
Phio Pharmaceuticals Corp. logo

Phio Pharmaceuticals Corp. (PHIO) stock

PHIONasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 5/30
$0.72−0.04 (-4.65%)

Close on Nov 17, 2026Market cap $8.33MP/E –Yield –

Phio Pharmaceuticals price to sales ratio

The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.

Phio Pharmaceuticals's price to sales ratio was 60.9× on Apr 30, 2020, against 66.9× a year earlier. Over the last 4 years it ranged from 9.6× to 471.2×, with a median of 103.4×.

Price to Sales Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2020Apr 30, 202060.9×−148.1
2019Dec 31, 2019208.9×+199.3
2018Dec 31, 20189.6×−432.9
2017Apr 28, 2017442.5×+194.4
2016Dec 30, 2016248.1×+174.0
2014Oct 31, 201474.1×−273.1
2013Apr 30, 2013347.2×–

More Phio Pharmaceuticals figures

See a number that looks wrong?